115 related articles for article (PubMed ID: 38251776)
61. Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.
Miyakita H; Chan LF; Okada K; Kayano H; Mori M; Sadahiro S; Yamamoto S
BMC Gastroenterol; 2022 Jul; 22(1):334. PubMed ID: 35804299
[TBL] [Abstract][Full Text] [Related]
62. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
63. Lymph node ratio is an independent prognostic factor in patients with rectal cancer treated with preoperative chemoradiotherapy and curative resection.
Lee SD; Kim TH; Kim DY; Baek JY; Kim SY; Chang HJ; Park SC; Park JW; Oh JH; Jung KH
Eur J Surg Oncol; 2012 Jun; 38(6):478-83. PubMed ID: 22465588
[TBL] [Abstract][Full Text] [Related]
64. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
65. Locally advanced rectal cancer: diffusion-weighted MR tumour volumetry and the apparent diffusion coefficient for evaluating complete remission after preoperative chemoradiation therapy.
Ha HI; Kim AY; Yu CS; Park SH; Ha HK
Eur Radiol; 2013 Dec; 23(12):3345-53. PubMed ID: 23812242
[TBL] [Abstract][Full Text] [Related]
66. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
67. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
Rombouts AJM; Hugen N; Verhoeven RHA; Elferink MAG; Poortmans PMP; Nagtegaal ID; de Wilt JHW
Eur J Surg Oncol; 2018 Jul; 44(7):1018-1024. PubMed ID: 29678303
[TBL] [Abstract][Full Text] [Related]
68. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
[TBL] [Abstract][Full Text] [Related]
69. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
70. The effect of neoadjuvant therapy on the size, number, and distribution of mesorectal lymph nodes.
Yegen G; Keskin M; Büyük M; Kunduz E; Balık E; Sağlam EK; Kapran Y; Asoğlu O; Güllüoğlu M
Ann Diagn Pathol; 2016 Feb; 20():29-35. PubMed ID: 26706785
[TBL] [Abstract][Full Text] [Related]
71. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
[TBL] [Abstract][Full Text] [Related]
72. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
73. Comparison of the pathological response of the mesorectal positive nodes between short-course chemoradiotherapy with delayed surgery and long-course chemoradiotherapy in patients with rectal cancer.
Beppu N; Kobayashi M; Matsubara N; Noda M; Yamano T; Doi H; Kamikonya N; Kakuno A; Kimura F; Yamanaka N; Yanagi H; Tomita N
Int J Colorectal Dis; 2015 Oct; 30(10):1339-47. PubMed ID: 26206348
[TBL] [Abstract][Full Text] [Related]
74. Prognostic significance of tumor regression in lymph nodes after neoadjuvant therapy for rectal carcinoma.
Fernández-Aceñero MJ; Granja M; Sastre J; García-Paredes B; Estrada L
Virchows Arch; 2016 Apr; 468(4):425-30. PubMed ID: 26754675
[TBL] [Abstract][Full Text] [Related]
75. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
[TBL] [Abstract][Full Text] [Related]
76. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
[TBL] [Abstract][Full Text] [Related]
77. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.
Kim JW; Kim HC; Park JW; Park SC; Sohn DK; Choi HS; Kim DY; Chang HJ; Baek JY; Kim SY; Kim SK; Oh JH
Int J Colorectal Dis; 2013 Sep; 28(9):1217-24. PubMed ID: 23404344
[TBL] [Abstract][Full Text] [Related]
78. MRI features of the complete histopathological response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Franklin JM; Anderson EM; Gleeson FV
Clin Radiol; 2012 Jun; 67(6):546-52. PubMed ID: 22218409
[TBL] [Abstract][Full Text] [Related]
79. Nonmetastatic ypt0 rectal cancer after neoadjuvant treatment and total mesorectal excision: Lessons from a retrospective multicentric cohort of 383 patients.
Collard MK; Rullier E; Panis Y; Manceau G; Benoist S; Tuech JJ; Alves A; Laforest A; Mege D; Cazelles A; Beyer-Berjot L; Christou N; Cotte E; Lakkis Z; O'Connell L; Parc Y; Piessen G; Lefevre JH;
Surgery; 2022 May; 171(5):1193-1199. PubMed ID: 35078629
[TBL] [Abstract][Full Text] [Related]
80. Pathologic complete response implies a fewer number of lymph nodes in specimen of rectal cancer patients treated by neoadjuvant therapy and total mesorectal excision.
Bustamante-Lopez LA; Nahas CSR; Nahas SC; Marques CFS; Pinto RA; Cotti GC; Imperiale AR; de Mello ES; Ribeiro U; Cecconello I
Int J Surg; 2018 Aug; 56():283-287. PubMed ID: 29981939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
